These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11152398)

  • 1. Removal of amphipathic epitopes from genetically engineered antibodies: production of modified immunoglobulins with reduced immunogenicity.
    Mateo C; Lombardero J; Moreno E; Morales A; Bombino G; Coloma J; Wims L; Morrison SL; Pérez R
    Hybridoma; 2000 Dec; 19(6):463-71. PubMed ID: 11152398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humanization of predicted T-cell epitopes reduces the immunogenicity of chimeric antibodies: new evidence supporting a simple method.
    Roque-Navarro L; Mateo C; Lombardero J; Mustelier G; Fernández A; Sosa K; Morrison SL; Pérez R
    Hybrid Hybridomics; 2003 Aug; 22(4):245-57. PubMed ID: 14511570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimizing the immunogenicity of antibodies for clinical application.
    Gonzales NR; De Pascalis R; Schlom J; Kashmiri SV
    Tumour Biol; 2005; 26(1):31-43. PubMed ID: 15741769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering fully human monoclonal antibodies from murine variable regions.
    Bernett MJ; Karki S; Moore GL; Leung IW; Chen H; Pong E; Nguyen DH; Jacinto J; Zalevsky J; Muchhal US; Desjarlais JR; Lazar GA
    J Mol Biol; 2010 Mar; 396(5):1474-90. PubMed ID: 20045416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity.
    Gonzales NR; Padlan EA; De Pascalis R; Schuck P; Schlom J; Kashmiri SV
    Mol Immunol; 2004 Jul; 41(9):863-72. PubMed ID: 15261458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the domain pairing in chimeric antibodies.
    Teplyakov A; Obmolova G; Carton JM; Gao W; Zhao Y; Gilliland GL
    Mol Immunol; 2010 Aug; 47(14):2422-6. PubMed ID: 20554002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A general approach to antibody thermostabilization.
    McConnell AD; Zhang X; Macomber JL; Chau B; Sheffer JC; Rahmanian S; Hare E; Spasojevic V; Horlick RA; King DJ; Bowers PM
    MAbs; 2014; 6(5):1274-82. PubMed ID: 25517312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SDR grafting--a new approach to antibody humanization.
    Kashmiri SV; De Pascalis R; Gonzales NR; Schlom J
    Methods; 2005 May; 36(1):25-34. PubMed ID: 15848072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein engineering of antibodies.
    Sandhu JS
    Crit Rev Biotechnol; 1992; 12(5-6):437-62. PubMed ID: 1423650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A germline knowledge based computational approach for determining antibody complementarity determining regions.
    Zhao S; Lu J
    Mol Immunol; 2010 Jan; 47(4):694-700. PubMed ID: 19939452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions.
    Harding FA; Stickler MM; Razo J; DuBridge RB
    MAbs; 2010; 2(3):256-65. PubMed ID: 20400861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering and characterization of a baculovirus-expressed mouse/human chimeric antibody against transferrin receptor.
    Shen X; Hu GB; Jiang SJ; He FR; Xing W; Li L; Yang J; Zhu HF; Lei P; Shen GX
    Protein Eng Des Sel; 2009 Dec; 22(12):723-31. PubMed ID: 19825853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells.
    Lunde E; Munthe LA; Vabø A; Sandlie I; Bogen B
    Nat Biotechnol; 1999 Jul; 17(7):670-5. PubMed ID: 10404160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides.
    Partidos C; Stanley C; Steward M
    Eur J Immunol; 1992 Oct; 22(10):2675-80. PubMed ID: 1382995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping a conserved conformational epitope from the M protein of group A streptococci.
    Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
    Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.